What happens at NIT?
This.
Why is NIT called a translator?
NIT is a Translator, focused on the translation of neurotechnology innovations from the lab to patients and the marketplace. We refer to NIT as a Translator, because it is fundamentally different from other types of programs. NIT is not an incubator; not an accelerator; not a venture capital firm; not a contract manufacturing house; not a clinical trialing organization.per se.Instead, NIT brings the best of what each of these other entities has tried to deliver, comprehensively, under one translational Center, borrowing their best attributes, but transforming them into an entity that provides a cocoon for your companys success in todays challenging landscape.
In stark contrast to other models, NIT holds ready investment capital for investment in early and advanced stages of your companys development. NIT focuses on a select number of high-quality, venture-fundable, commercially-oriented companies. NIT sources projects globally, while also having access to a rich pipeline of innovation. And, NIT leverages a robust infrastructure of on-site and nearby resources from already-committed Partners. The result: a comprehensive solution, providing the expertise, resources, and capital to propel your company from concept-to-clinic, and subsequently to commercial success.
What types of companies is NIT seeking?
NIT will develop a select number of high-quality, venture-fundable, commercially-oriented companies focused on neurotechnology innovation. NIT companies will be carefully chosen, funded, and nurtured within the NIT ecosystem only if they: (1) demonstrate a sufficient level of scientific validation and mitigation (or manageability) of technical risks; (2) target a clear unmet clinical need; and (3) carry the force of a market imperative with a well-focused business plan and model that meet private venture capital funding criteria. The mix of NIT companies chosen will include neurotechnology innovations that are both Dare-To-Dream projects, as well as Better, Faster, Cheaper solutions to improve patient care.
How can our innovation be considered for NIT investment?
Wed love to hear from you. Contact us.
Does NIT have dedicated funds?
Yes, NIT has capital ready to fund your company--not just to get your company started, but to propel your company forward in each development and investment stage. Whether seeding your company, leading, or joining an investment syndicate, NIT offers dedicated strategic investment funds, as well as available capital resources from a variety of Partners including Ohio Third Frontier and The Ohio State University. NIT can invest alone or as part of a syndicate to ensure your company is adequately capitalized.
How much does NIT invest?
NIT has no set expectations for funding levels either in a given round, or over the life of a company. The amount of money a prospective NIT Company may receive from NIT is driven by the business needs and specifics of a companys operating plans and objectives. We may invest as little as $250k, or as much as $10M, depending upon the projects specific needs.
We only have an idea for an innovation. Is NIT appropriate for us?
Of course! Whether an idea on a napkin, or a more mature and established neurotechnology company that is further along in the development pathway, NIT is seeking the best innovations in neurotechnology, regardless of stage or origin. NIT could be the perfect ecosystem for taking your idea and translating it from concept-to-clinic.Wed love to hear from you.
We've already been working on our startup for a while. Is NIT appropriate for us?
Yes.Whether NIT is seeding a company, NIT is leading an investment, or NIT is joining an investment syndicate, provided your company can capitalize on the resources and ecosystem that we have to offer, we are interested. NIT has dedicated strategic investment funds, as well as available capital resources from a variety of Partners including Ohio Third Frontier and The Ohio State University for investment in your startup.
We've already taken some funding. Is NIT appropriate for us?
Sure. As mentioned above, whether NIT is seeding a company, NIT is leading an investment, or NIT is joining an investment syndicate, provided your company can capitalize on the resources and ecosystem that we have to offer, we are interested. We can probably help any startup that hasn't already raised an inordinate amount of capital, (e.g. already entering a third investment round from institutional investors). If you are unsure, contact us and we will let you know directly.
Will NIT syndicate alongside other investors and co-invest?
Yes, absolutely. Provided, however, that a company would significantly benefit from NITs resources and ecosystem for its development pathway.
We need investment capital, but already have all the resources we need. Is NIT appropriate for us?
NIT is not a venture capital firm. The capital NIT invests is only a small part of what NIT brings from its ecosystem for company development. If all that your company needs is investment capital, it is likely not a fit for NIT.
Will NIT invest in a company that is not in Ohio?
No. Your company might be able to leave a few employees at home, but the company needs to be headquartered in Ohio to attract NITs resources and investment capital. NIT and Ohio offer so much to companies, that unless your company is located within this ecosystem, it would likely not benefit from all the resources that NIT might bring.
Do we have to start a company in the US for you to invest in us?
No, not necessarily. NIT seeks projects from around the globe. If you've started your company outside the US (or outside of Ohio for that matter), and are interested in relocating to Ohio to tap into the NIT ecosystem, we would love to hear from you.
Do we have to work with your Partners?
No, not necessarily. NITs broad Partner ecosystem is there to help your company. We wouldnt expect your company to need all of themnor would we demand that you have to work with any specific Partner. That said, of course we would want to ensure that your company would sufficiently benefit from NITs resources and ecosystem for its development pathway to make the investment mutually beneficial.
What if we have a conflict with one of the NIT Partners?
NITs Partners are there for your company as needed. As a private entity, NIT is wholly separated. So, NIT can work independently with your company without any exposure to any particular Partner, as necessary.
Does our company need to use NITs facility?
Not necessarily. While NIT offers substantial space, facilities, and onsite resources, NIT Companies can locate anywhere within Ohio that is most conducive to their success.Some may reside initially within the NIT Center itself, some may be established elsewhere within Ohio, depending upon their specific needs and capabilities. Eventually your company will leave the facility in any respect, and matriculate outside and beyond NIT, within Ohio, as you reach your milestones and are funded as a fully independent company.
Will NIT sign an NDA?
No, NIT won't typically sign an NDA. Like a venture capital firm, we review far too many projects to sign NDAs, and believe that most of our exploratory conversations can be held without any exchange of sensitive proprietary information. And, as an experienced entrepreneur, you appreciate the relatively limited value of the idea itself, relative to the long path to execution that lies ahead for your company.
Is NIT hiring?
For a list of available opportunities at NIT or one of NITs Companies, click here.
Follow this link:
FAQ Neurotechnology Innovations Translator
- Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) - December 8th, 2016 [December 8th, 2016]
- Backing British innovation: Royal Academy of Engineering launches ... - Elite Business Magazine - February 13th, 2017 [February 13th, 2017]
- Global Fingerprint Biometrics in the VAR Market 2016 Fulcrum Biometrics, Neurotechnology, 360 Biometrics ... - Albanian Times - February 16th, 2017 [February 16th, 2017]
- Israel and Indiana: Why You're Getting an Invitation to the Holy Land ... - 93.1 WIBC Indianapolis - February 22nd, 2017 [February 22nd, 2017]
- 5th Annual Big Idea Competition Nets Three Winners Colorado ... - Colorado College News - February 23rd, 2017 [February 23rd, 2017]
- 3Q: US Patent Office's Ruling on CRISPR - Bioscience Technology - February 24th, 2017 [February 24th, 2017]
- 7 reasons you must attend WIRED Health 2017 - Wired.co.uk - February 24th, 2017 [February 24th, 2017]
- Edward Boyden - Big Think - February 25th, 2017 [February 25th, 2017]
- What Health Care Can Learn from Wal-Mart - Wall Street Journal (subscription) (blog) - March 4th, 2017 [March 4th, 2017]
- A report released today by RBC Capital Markets about Stryker Corporation (NYSE:SYK) ups the target price to $135.00 - Breaking Finance News - March 4th, 2017 [March 4th, 2017]
- Paralysis patients achieve fastest typing yet with new brain-computer interface - The Brown Daily Herald - March 7th, 2017 [March 7th, 2017]
- How 'brain wearables' can address 21st century needs - IoT Tech News - March 7th, 2017 [March 7th, 2017]
- Stryker's AVAflex Vertebral Balloon System Receives FDA 510(k ... - OrthoSpineNews - March 8th, 2017 [March 8th, 2017]
- Stryker's Spine Division To Feature Novel 3D-Printed Spinal Implants at AAOS Conference - OrthoSpineNews - March 9th, 2017 [March 9th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- How to ensure future brain technologies will help and not harm society - USAPP American Politics and Policy (blog) - March 10th, 2017 [March 10th, 2017]
- Preview: MedX Future of Healthcare conference - The Mancunion - March 11th, 2017 [March 11th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - OrthoSpineNews - March 11th, 2017 [March 11th, 2017]
- Elon Musk Wants to Merge Man and MachineHere's What He'll ... - Observer - April 8th, 2017 [April 8th, 2017]
- Synchron Inc. Secures $10 Million in Series A Financing Round - PR Newswire (press release) - April 8th, 2017 [April 8th, 2017]
- How Neurotechnology Is Helping The San Francisco Giants Train Better - PSFK (subscription) - April 8th, 2017 [April 8th, 2017]
- Positive Media Coverage Very Likely to Affect Stryker (SYK) Share Price - Chaffey Breeze - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m investment - Scottish Legal News - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m (EUR) investment - Shoosmiths legal updates (press release) - June 7th, 2017 [June 7th, 2017]
- Comparing Accuray (ARAY) & Stryker (SYK) - The Cerbat Gem - June 9th, 2017 [June 9th, 2017]
- Welch Capital Partners Increased By $3.59 Million Its Eqt (EQT) Position, Stryker (SYK) Sellers Decreased By 3.59 ... - UtahHerald.com - June 10th, 2017 [June 10th, 2017]
- Head to Head Analysis: Accuray (ARAY) and Stryker Corporation (SYK) - Sports Perspectives - June 13th, 2017 [June 13th, 2017]
- Neurotechnology Announces MegaMatcher Accelerator Extreme ... - findBIOMETRICS - June 13th, 2017 [June 13th, 2017]
- Comparing Stryker Corporation (SYK) & Accuray (ARAY) - Markets Daily - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Releases MegaMatcher Accelerator Extreme, the Fastest Biometric Engine in the World - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotech panel shares successes from first year - Cornell Chronicle - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Researchers Win Kaggle Competition with Deep Neural Network Solution for The Nature ... - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Wins Fisheries-Focused Computer Vision Competition - findBIOMETRICS - June 14th, 2017 [June 14th, 2017]
- Helping or Hacking? Engineers, Ethicists Must Work Together on Brain-Computer Interface Technology - Government Technology - June 16th, 2017 [June 16th, 2017]
- Accuray (ARAY) versus Stryker Corporation (SYK) Head-To-Head Review - The Cerbat Gem - June 17th, 2017 [June 17th, 2017]
- The Funded: Justin Kan's latest startup gets backing from more than 100 investors - Silicon Valley Business Journal - June 17th, 2017 [June 17th, 2017]
- New SentiVeillance Server from Neurotechnology Adds Face Recognition and Analytics to Video Management Systems - PR Newswire (press release) - June 20th, 2017 [June 20th, 2017]
- Neurotechnology Announces SentiVeillance Server Facial Recognition Solution - findBIOMETRICS - June 20th, 2017 [June 20th, 2017]
- SentiVeillance Server - Face Recognition and Analytics to Video Management Systems - Officer.com (press release) (registration) (blog) - June 21st, 2017 [June 21st, 2017]
- Neurotechnology Announces MegaMatcher 10 - findBIOMETRICS - June 21st, 2017 [June 21st, 2017]
- Neurotechnology adds face recognition, tracking to video surveillance systems; researchers win competition - Biometric Update - June 22nd, 2017 [June 22nd, 2017]
- Neurotechnology makes a number of updates to the MegaMatcher product line - Biometric Update - June 23rd, 2017 [June 23rd, 2017]
- Neurotechnology Develops 3D Printing Method with Non-Contact Ultrasonic Manipulation Technology - 3DPrint.com - June 26th, 2017 [June 26th, 2017]
- Mind-blowing ultrasonic 'printer' uses lasers and high-frequency sound to assemble electronics - Digital Trends - June 29th, 2017 [June 29th, 2017]
- HIRREM Neurotechnology Better Than Placebo for Insomnia - Sleep Review - July 10th, 2017 [July 10th, 2017]
- DARPA invests further in neurotechnology - SD Times - SDTimes.com - July 14th, 2017 [July 14th, 2017]
- Infinitely Flexible 3D Printing with Ultrasonic Manipulation? - ENGINEERING.com - July 15th, 2017 [July 15th, 2017]
- Insider Activity Stryker Corporation (NYSE:SYK) - Highlight Press - July 16th, 2017 [July 16th, 2017]
- Comparing Uroplasty (UPI) and Stryker Corporation (NYSE:SYK) - The Cerbat Gem - July 17th, 2017 [July 17th, 2017]
- Biomimetic Underwater Robot Program - July 17th, 2017 [July 17th, 2017]
- Preserving the Right to Cognitive Liberty - Scientific American - July 18th, 2017 [July 18th, 2017]
- BRAIN center gathers to ponder future, direction - Arizona State University - July 20th, 2017 [July 20th, 2017]
- Stryker Expands Its Interventional Spine Segment - Market Realist - July 22nd, 2017 [July 22nd, 2017]
- Trivascular Technologies (TRIV) & Stryker Corporation (SYK) Critical Review - Stock Observer - July 26th, 2017 [July 26th, 2017]
- Arshya Vahabzadeh: Innovating at the Intersection of Brain ... - HuffPost - July 27th, 2017 [July 27th, 2017]
- fMRI and EEG May Be Able to Reveal Consciousness in Comatose Patients - Physical Therapy Products - July 29th, 2017 [July 29th, 2017]
- Stryker reports 6.1% Q2 growth, installs 26 Mako systems: 7 things to know - Becker's Orthopedic & Spine - July 29th, 2017 [July 29th, 2017]
- Tufts Hosts Engineering Conference - Tufts Now - July 29th, 2017 [July 29th, 2017]
- Stryker Corporation (NYSE:SYK) and Uroplasty (UPI) Financial Survey - Stock Observer - July 29th, 2017 [July 29th, 2017]
- Elon Musk speaks of being 'bipolar' on Twitter - Mashable - July 31st, 2017 [July 31st, 2017]
- Team Neurotechnology Innovations Translator - July 31st, 2017 [July 31st, 2017]
- Elon Musk opens up about the highs and lows of his life on Twitter - Firstpost - August 1st, 2017 [August 1st, 2017]
- Train your brain at Ky learning centre - Shepparton News - August 2nd, 2017 [August 2nd, 2017]
- Stryker Exceeded Analysts' Sales Estimates in 2Q17 - Market Realist - August 2nd, 2017 [August 2nd, 2017]
- $2.6 million to build versatile genetic toolkit for studying animal ... - Washington University in St. Louis Newsroom - August 3rd, 2017 [August 3rd, 2017]
- National Science Foundation $9M grant will fund neurotech research hub at Cornell - The Ithaca Voice - August 3rd, 2017 [August 3rd, 2017]
- NSF awards Cornell $9M grant for neurotech research hub - The Central New York Business Journal - August 4th, 2017 [August 4th, 2017]
- NSF issues awards to advance a national research infrastructure for neuroscience - National Science Foundation (press release) - August 4th, 2017 [August 4th, 2017]
- $9M Grant Will Create Neurotech Research Hub - Lansing Star - August 4th, 2017 [August 4th, 2017]
- NSF backs photonics-enabled neuroscience networks - Optics.org - August 9th, 2017 [August 9th, 2017]
- Washington University awarded $2.6 million for neurotechnology research - St. Louis Business Journal - August 9th, 2017 [August 9th, 2017]
- fMRI, EEG may detect consciousness in TBI patients - Medical Physics Web (subscription) - August 10th, 2017 [August 10th, 2017]
- Financial Analysis: Stryker Corporation (NYSE:SYK) vs. Uroplasty (UPI) - The Cerbat Gem - August 12th, 2017 [August 12th, 2017]
- In the Future, Humans Will Use Brain to Brain Communication and Download Their Memories If Elon Musk Has His Way - Newsweek - August 13th, 2017 [August 13th, 2017]
- How Elon Musk Plans to Turn Humans Into Robots - Yahoo News - August 14th, 2017 [August 14th, 2017]
- Critical Comparison: Stryker Corporation (SYK) versus Glaukos Corporation (GKOS) - TrueBlueTribune - August 21st, 2017 [August 21st, 2017]
- Early career scientists named Mong Fellows in Cornell Neurotech - Cornell Chronicle - August 21st, 2017 [August 21st, 2017]
- Could this back-pain device end need for opioids? - The Columbus Dispatch - August 21st, 2017 [August 21st, 2017]
- New technologies to diagnose and treat neurological diseases - Medical Xpress - August 22nd, 2017 [August 22nd, 2017]